During the past decade, Ch Calais conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ch Calais" #1 sponsor was "University Hospital, Lille" with 6 trials, followed by "Centre Francois Baclesse" with 1 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored, "Centre Leon Berard" with 1 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ch Calais" #1 collaborator was "Groupement Interrégional de Recherche Clinique et d'Innovation" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator and "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Ch Calais" are "Breast Cancer" (2 trials), "Cancer" (2 trials), "Hypertension" (2 trials), "Stroke" (2 trials) and "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials). Many other conditions were trialed in "Ch Calais" in a lesser frequency.

Most popular intervention types in "Ch Calais" are "Other" (7 trials), "Drug" (5 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AVP-786" (1 trials), "Archival Tumor Tissue Sample" (1 trials), "Avelumab" (1 trials) and "Blood pressure management policies" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ch Calais" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ch Calais". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ch Calais, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ch Calais, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".